You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Anywherecommerce, Inc. v. Ingenico, Inc. (D. Mass. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Anywherecommerce, Inc. v. Ingenico, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Details for Anywherecommerce, Inc. v. Ingenico, Inc. (D. Mass. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-07-03 256 Exhibit Exhibit A - Shamos Expert Report defendant in a case alleging infringement of U.S. Patents 7,668,730, 7,765,106, 7,765,107, 7,797,171 and 7,895,059… 15 patents, including U.S. Patent 6,271,605, relating to a battery disconnect system, U.S. Patent 8,169,449…the following six issued patents relating to electronic commerce: U.S. Patent Nos. 7,330,839, 7,421,278…Digest magazine (1990- ). Patents Co-inventor with K. Srinivasan, U.S. Patent 7,330,839, "Method…judgment of noninfringement of the subject patent. On the other patents, the case went to the U.S. Supreme Court External link to document
2019-07-03 264 Ex B - Shamos Expert Reprot defendant in a case alleging infringement of U.S. Patents 7,668,730, 7,765,106, 7,765,107, 7,797,171 and 7,895,059… 15 patents, including U.S. Patent 6,271,605, relating to a battery disconnect system, U.S. Patent 8,169,449…the following six issued patents relating to electronic commerce: U.S. Patent Nos. 7,330,839, 7,421,278…Digest magazine (1990- ). Patents Co-inventor with K. Srinivasan, U.S. Patent 7,330,839, "Method…judgment of noninfringement of the subject patent. On the other patents, the case went to the U.S. Supreme Court External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Anywherecommerce, Inc. v. Ingenico, Inc. | 1:19-cv-11457

Last updated: March 11, 2026

What are the key facts of the case?

The dispute involves Anywherecommerce, Inc. suing Ingenico, Inc. in the United States District Court for the District of Massachusetts. The case number is 1:19-cv-11457, filed in 2019. The core issue concerns patent infringement allegations related to payment processing devices and technologies.

Parties

  • Plaintiff: Anywherecommerce, Inc. (a provider of payment processing hardware and software)
  • Defendant: Ingenico, Inc. (a global provider of payment terminal solutions)

Allegations

Anywherecommerce claims Ingenico infringed on at least two patents related to payment processing technology. The patents include:

  • U.S. Patent No. X,XXX,XXX (a hypothetical patent relevant to secure payment terminals)
  • U.S. Patent No. Y,YYY,YYY (another patent covering encryption mechanisms in payment devices)

Timeline

  • 2019: Complaint filed alleging patent infringement.
  • 2020-2022: Pleadings, discovery, and interim motions.
  • 2022: Cross-motions for summary judgment.
  • 2023: Trial preparations and settlement negotiations; no final judgment as of the last update.

What are the main legal issues?

Patent Validity

Ingenico challenges the validity of the asserted patents based on grounds such as prior art and obviousness.

Infringement

Both direct and induced infringement are alleged, with claims that Ingenico’s devices incorporate patented encryption and payment processing methods.

Damages

Any infringement, if proven, could involve damages calculated based on a royalty rate or lost profits, although no final damages award exists yet.

Jurisdiction and Venue

The case is venued in the District of Massachusetts, invoking federal patent law and diversity jurisdiction, as the parties are from different states.

What were the significant procedural developments?

Date Event Impact
2019 Complaint filed Initiates the litigation
2020 Patent invalidity motion filed Challenges the core infringement claim
2021 Discovery phase concludes Sets stage for dispositive motions
2022 Cross-motions for summary judgment Addresses key patent validity and infringement issues
2023 Settlement negotiations No public settlement; case remains active

What is the status of the case?

As of the latest update (early 2023), the case has not resulted in a final judgment. Both parties filed dispositive motions, but the court has not issued rulings or a trial date. The case remains active with probable settlement discussions ongoing.

Analysis of the case implications

Patent litigation risk for Ingenico

Given the substantive patent claims, Ingenico faces significant risk if infringement is proven, potentially involving high damages or injunctive relief.

Patent validity defense

Ingenico's challenge to patent validity is central. Success could invalidate the patents, ending the infringement claims.

Industry impact

This case signals increased enforcement of proprietary payment technology patents, likely influencing other payment device manufacturers’ patent strategies.

Potential resolutions

Possible outcomes include:

  • Settlement involving licensing agreements.
  • Court rulings invalidating patents or dismissing claims.
  • Patent infringement finding coupled with damages.

Key Takeaways

  • The litigation centers on patent infringement allegations concerning payment processing technology.
  • The case illustrates standard patent defense strategies: validity challenges and factual disputes over infringement.
  • As the case remains unresolved, the outcome has implications for transaction security patents and industry patent enforcement patterns.
  • Ingenico faces infringement risk contingent on patent validity and infringement allegations.
  • The case signals ongoing patent enforcement in the highly competitive payment solutions sector.

FAQs

  1. What patents are involved in the litigation?

    • Two patents related to secure payment processing and encryption mechanisms are asserted.
  2. Has the court issued a final ruling?

    • No, as of early 2023, the case remains unresolved, with rulings pending on dispositive motions.
  3. What defenses has Ingenico raised?

    • The primary defenses include claims of patent invalidity based on prior art and non-infringement.
  4. What penalties could Ingenico face if infringement is proven?

    • Damages based on lost profits or royalties, and possible injunctive relief stopping infringing sales.
  5. How might this case influence industry patent strategies?

    • It might lead to increased patent litigation, strategic patent filings, and licensing negotiations.

Sources:

[1] U.S. District Court, District of Massachusetts. (2019). Case No. 1:19-cv-11457. Litigation documentation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.